- Home
- HVT vs TECX Comparison
HVT vs TECX Comparison
Compare HVT & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HVT
- TECX
- Stock Information
- Founded
- HVT 1885
- TECX 2019
- Country
- HVT United States
- TECX United States
- Employees
- HVT N/A
- TECX N/A
- Industry
- HVT Other Specialty Stores
- TECX
- Sector
- HVT Consumer Discretionary
- TECX
- Exchange
- HVT Nasdaq
- TECX Nasdaq
- Market Cap
- HVT 317.1M
- TECX 334.4M
- IPO Year
- HVT N/A
- TECX 2018
- Fundamental
- Price
- HVT $22.40
- TECX $21.69
- Analyst Decision
- HVT
- TECX Buy
- Analyst Count
- HVT 0
- TECX 6
- Target Price
- HVT N/A
- TECX $78.67
- AVG Volume (30 Days)
- HVT 114.7K
- TECX 241.7K
- Earning Date
- HVT 07-30-2025
- TECX 08-13-2025
- Dividend Yield
- HVT 5.71%
- TECX N/A
- EPS Growth
- HVT N/A
- TECX N/A
- EPS
- HVT 1.28
- TECX N/A
- Revenue
- HVT $720,469,000.00
- TECX N/A
- Revenue This Year
- HVT $4.96
- TECX N/A
- Revenue Next Year
- HVT $8.28
- TECX N/A
- P/E Ratio
- HVT $17.49
- TECX N/A
- Revenue Growth
- HVT N/A
- TECX N/A
- 52 Week Low
- HVT $17.01
- TECX $13.70
- 52 Week High
- HVT $29.85
- TECX $61.07
- Technical
- Relative Strength Index (RSI)
- HVT 69.94
- TECX 51.82
- Support Level
- HVT $20.08
- TECX $19.13
- Resistance Level
- HVT $20.73
- TECX $21.46
- Average True Range (ATR)
- HVT 0.61
- TECX 1.27
- MACD
- HVT 0.24
- TECX -0.00
- Stochastic Oscillator
- HVT 99.04
- TECX 70.50
About HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.